Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Ev… (NCT05606042) | Clinical Trial Compass
TerminatedNot Applicable
Curvafix® Intramedullary System for Fixation of Pelvic and Acetabular Fractures, A Post Market Evaluation
Stopped: low enrollment
United States53 participantsStarted 2021-11-24
Plain-language summary
Prospective, single arm, post-market evaluation to evaluate the use and performance of the IM Implant in a post market setting.
Who can participate
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subject, or their Authorized Representative, is willing and able to provide written informed consent, including authorization to release health information
* Subject has undergone pelvic or acetabular fixation using the IM Implant and the IM Implant was placed according to the manufacturer's labeling.
* Subject's pelvic or acetabular fixation with the IM Implant occurred within the last 30 calendar days.
Exclusion Criteria:
* Subject is unwilling or unable to provide written informed consent and/or does not have an authorized representative who can provide consent on their behalf
* Subject presents with any condition or situation which, in the Investigator's opinion, puts the Subject at risk, could confound the study results, or may interfere with the Subject's participation in the study